CapitolRadar tracks every publicly disclosed EW trade by US congress members and corporate insiders: 42 disclosed trades (25 buys, 17 sells) by 6 tracked traders, from 2019-03-20 to 2026-05-01. Updated daily from official filings.
Want a ping when Congress buys EW? Free email alerts on notable disclosed trades — plus a $100,000 fantasy portfolio to play along against three AI traders. Join free
Edwards Lifesciences Corporation (EW) — Healthcare · Medical - Devices, market cap about $49.4B.
CapitolRadar analysis
41 tracked EW trades skewed toward purchases
Edwards Lifesciences Corporation (EW), in the Healthcare / Medical - Devices industry, had 41 tracked congressional trades from March 29, 2021 through May 1, 2026. The total comprises 25 buys and 16 sells by five distinct traders. Buys therefore accounted for 25 of 41 transactions, while sells accounted for 16.
The sample is small: only five traders are represented, and transaction counts do not establish the size, conviction, or motivation behind any trade. Congressional disclosures can be filed up to 45 days after a transaction, so reported activity may lag the actual trade date. Transaction values are generally disclosed in ranges, making any amount-based totals estimates; no transaction amounts are included in this dataset.
19 of 25 buys came from Ro Khanna
Ro Khanna recorded 19 EW buys, representing most of the 25 tracked purchases, with the latest dated May 1, 2026. Markwayne Mullin and Diana Harshbarger each had two buys, most recently on October 3, 2023 and January 25, 2023, respectively. Josh Gottheimer had one buy dated December 11, 2023, and Tommy Tuberville had one dated March 29, 2021.
This concentration means the buy count is not broadly distributed across the five traders. It is primarily a record of repeated purchases by one buyer, with four others contributing six buys combined.
6 trades in 2023 Q4 versus 1 in each 2026 quarter
Among the listed quarterly figures, 2023 Q4 was the busiest, with six trades and two buys. 2023 Q3 had four trades and three buys. More recent listed quarters were sparse: 2025 Q4 had two sells, 2026 Q1 had one sell, and 2026 Q2 had one buy.
Cross-ticker overlap was also limited. Two of the five EW buyers also bought each of FCX, PANW, ADI, and GOOGL. One also bought AJG, and one also bought AXP. Given the small group, these overlaps should be read as descriptive counts rather than evidence of a shared trading pattern.
Analysis written from the tracked record on 2026-09-05; it is refreshed whenever the underlying numbers change.
Activity by quarter
| Quarter | Disclosed trades | Buys | Sells |
|---|---|---|---|
| 2026 Q2 | 1 | 1 | 0 |
| 2026 Q1 | 1 | 0 | 1 |
| 2025 Q4 | 2 | 0 | 2 |
| 2024 Q4 | 1 | 1 | 0 |
| 2024 Q3 | 2 | 1 | 1 |
| 2024 Q1 | 1 | 1 | 0 |
| 2023 Q4 | 6 | 2 | 4 |
| 2023 Q3 | 4 | 3 | 1 |
Who is buying EW?
| Trader | Disclosed buys | Last buy | Grade |
|---|---|---|---|
| Ro Khanna | 19 | 2026-05-01 | — |
| Markwayne Mullin | 2 | 2023-10-03 | — |
| Diana Harshbarger | 2 | 2023-01-25 | — |
| Josh Gottheimer | 1 | 2023-12-11 | — |
| Tommy Tuberville | 1 | 2021-03-29 | — |
Disclosed trades in EW
| Date | Who | Type | Amount | 30d vs SPY |
|---|---|---|---|---|
| 2026-05-01 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-01-13 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2025-11-19 | Josh Gottheimer | sell | $1,001 - $15,000 | — |
| 2025-10-07 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2024-10-14 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2024-09-09 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2024-08-20 | Markwayne Mullin | sell | $15,001 - $50,000 | — |
| 2024-02-13 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-12-11 | Josh Gottheimer | buy | $1,001 - $15,000 | — |
| 2023-11-03 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2023-10-31 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2023-10-26 | Ro Khanna | sell | $15,001 - $50,000 | — |
| 2023-10-03 | Markwayne Mullin | buy | $1,001 - $15,000 | — |
| 2023-10-02 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2023-09-13 | Markwayne Mullin | buy | $15,001 - $50,000 | — |
| 2023-08-29 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-08-11 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-07-28 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2023-05-23 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-04-25 | Ro Khanna | buy | $1,001 - $15,000 | — |
These buyers also bought
Other stocks the tracked buyers of EW disclosed buying in the last six months: ADI (2) · GOOGL (2) · SNDK (2) · RSG (2) · AMD (2) · MSFT (2).
About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and…
Frequently asked questions
Which politicians bought EW most?
Ro Khanna leads with 19 disclosed buys, followed by Markwayne Mullin.
How current is this page?
It re-renders from the tracked record on every view and new filings are ingested daily — but STOCK Act disclosures can lag the trade by up to 45 days, so the most recent weeks are always incomplete.
Get alerts when trades like these are disclosed. Free account: fantasy portfolio + email alerts. Premium: a 6-hour head start on every signal.
CapitolRadar tracks publicly disclosed trades (STOCK Act filings and SEC Form 4). Disclosures can lag the trade by up to 45 days. Backtests measure past disclosed buys against the S&P 500 and do not predict future results. Everything on this page is impersonal information for your own research — not investment advice.